Boulos Patrick R, Harissi-Dagher Mona, Kavalec Conrad, Hardy Isabelle, Codère François
Sainte-Justine Hospital, Montréal, Québec, Canada.
Ophthalmic Plast Reconstr Surg. 2005 May;21(3):171-6. doi: 10.1097/01.iop.0000160594.06829.00.
Surgical removal of orbital lymphangiomas is often difficult because the capsule of these lesions is fragile, and, once violated, it tends to collapse, making identification of residual tumor difficult and dissection often incomplete. A surgical technique combining partial controlled decompression of the lesion with intralesional injection of Tisseel fibrin glue is evaluated to determine its effectiveness in resecting the lesion and preventing recurrences.
This is a retrospective interventional case series. Three young patients, two with lymphangiomas and one with congenital hydrocystoma, underwent surgical resection of their thin-walled cystic lesions of the orbit with the use of intralesional injection of Tisseel fibrin glue. Resolution of the signs and symptoms, complications of the surgery, and recurrence of bleeding are the parameters studied.
All 3 patients had improvement of their signs and symptoms. None had complications related to the surgery, and no recurrence of bleeding occurred during the follow-up period.
Our study suggests that this surgical technique with intralesional injection of Tisseel fibrin glue is an effective treatment modality for the resection of lymphangiomas and other orbital thin-walled cystic lesions.
眼眶淋巴管瘤的手术切除往往具有挑战性,因为这些病变的包膜很脆弱,一旦被破坏就容易塌陷,这使得识别残留肿瘤变得困难,而且手术切除常常不彻底。我们评估了一种将病变部分控制性减压与瘤内注射Tisseel纤维蛋白胶相结合的手术技术,以确定其在切除病变和预防复发方面的有效性。
这是一项回顾性介入病例系列研究。三名年轻患者,两名患有淋巴管瘤,一名患有先天性水囊瘤,接受了眼眶薄壁囊性病变的手术切除,并在瘤内注射了Tisseel纤维蛋白胶。研究的参数包括体征和症状的缓解情况、手术并发症以及出血复发情况。
所有3例患者的体征和症状均有改善。无一例出现与手术相关的并发症,随访期间也未发生出血复发。
我们的研究表明,这种瘤内注射Tisseel纤维蛋白胶的手术技术是切除淋巴管瘤和其他眼眶薄壁囊性病变的一种有效治疗方式。